Prototypes of SARS-CoV-2 virus “traps” based on enterosorbents

Author:

Shulmeyster G. A.1,Cheburkin Yu. V.1,Chekmeneva Yu. D.2,Edemskaya E. V.2,Bondarenko A. B.3,Postnov V. N.4,Korolev D. V.5

Affiliation:

1. Almazov National Medical Research Centre

2. Saint Petersburg Electrotechnical University “LETI”

3. Almazov National Medical Research Centre; Saint Petersburg State Pediatric Medical University

4. Almazov National Medical Research Centre; Saint Petersburg State University

5. Almazov National Medical Research Centre; Academician I. P. Pavlov First Saint Petersburg State Medical University

Abstract

   Background. Despite the ongoing mutations of the SARS-CoV-2 virus, the causative agent of the COVID-19 disease, its mechanism of entry into the cell remains unchanged, which can be used to create virus “traps”. Intravenous medications aggravate the symptoms of the disease. An alternative means of combating the virus could be enterosorbents synthesized on nanosized carriers that intercept SARS-CoV-2 directly at the site of its introduction into the body, namely in the gastrointestinal tract.   Objective. To study and refine the methods of synthesis of different spacer types on the surface of aerosil nanoparticles, immobilization of model protein with the possibility of using the compounds as enterosorbents of SARS-CoV-2 virus.   Design and method. Aerosil A-200 grade was used as carrier nanoparticles. The chemical composition of the obtained compounds was studied by FTIR spectroscopy. The absorption spectra of the samples were studied using a spectrophotometer. The dimensions of nano-objects were determined by dynamic light scattering. Qualitative and quantitative determination of protein chemisorption on the synthesized particles was carried out.   Results. Prototypes of SARS-CoV-2 enterosorbents on aerosil particles were developed. The efficacy of the spacers was tested on the model protein, albumin.   Conclusion. Further research may be directed to the development of an oral drug that reduces the viral load of SARS-CoV-2.

Publisher

Arterialnaya Gipertenziya

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3